Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study
Five-year breast cancer survivors, diagnosed after 65 years of age, may develop more incident comorbidities than similar populations free of cancer. We investigated whether older breast cancer survivors have a similar comorbidity burden 6–15 years after cancer diagnosis to matched women free of brea...
Uloženo v:
| Vydáno v: | Breast cancer research and treatment Ročník 146; číslo 2; s. 401 - 409 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Boston
Springer US
01.07.2014
Springer Springer Nature B.V |
| Témata: | |
| ISSN: | 0167-6806, 1573-7217, 1573-7217 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Five-year breast cancer survivors, diagnosed after 65 years of age, may develop more incident comorbidities than similar populations free of cancer. We investigated whether older breast cancer survivors have a similar comorbidity burden 6–15 years after cancer diagnosis to matched women free of breast cancer at start of follow-up and whether incident comorbidities are associated with all-cause mortality. In this prospective cohort study, 1,361 older 5-year early-stage breast cancer survivors diagnosed between 1990 and 1994 and 1,361 age- and health system-matched women were followed for 10 years. Adjudicated medical record review captured prevalent and incident comorbidities during follow-up or until death as collected from the National Death Index. Older 5-year breast cancer survivors did not acquire incident comorbidities more often than matched women free of breast cancer in the subsequent 10 years [hazard ratio (HR) 1.0, 95 % confidence interval (95 % CI) 0.93, 1.1]. Adjusted for cohort membership, women with incident comorbidities had a higher mortality rate than those without incident comorbidities (HR 4.8, 95 % CI 4.1, 5.6). A breast cancer history continued to be a hazard for mortality 6–15 years after diagnosis (HR 1.3, 95 % CI 1.1, 1.4). We found that older breast cancer survivors who developed comorbidities had an increased all-cause mortality rate even after adjusting for age and prevalent comorbidity burden. Additionally, survivors acquire comorbidities at a rate similar to older women free of breast cancer. These results highlight the association between comorbidity burden and long-term mortality risk among older breast cancer survivors and their need for appropriate oncology and primary care follow-up. |
|---|---|
| AbstractList | Five-year breast cancer survivors, diagnosed after 65 years of age, may develop more incident comorbidities than similar populations free of cancer. We investigated whether older breast cancer survivors have a similar comorbidity burden 6-15 years after cancer diagnosis to matched women free of breast cancer at start of follow-up and whether incident comorbidities are associated with all-cause mortality. In this prospective cohort study, 1,361 older 5-year early-stage breast cancer survivors diagnosed between 1990 and 1994 and 1,361 age- and health system-matched women were followed for 10 years. Adjudicated medical record review captured prevalent and incident comorbidities during follow-up or until death as collected from the National Death Index. Older 5-year breast cancer survivors did not acquire incident comorbidities more often than matched women free of breast cancer in the subsequent 10 years [hazard ratio (HR) 1.0, 95 % confidence interval (95 % CI) 0.93, 1.1]. Adjusted for cohort membership, women with incident comorbidities had a higher mortality rate than those without incident comorbidities (HR 4.8, 95 % CI 4.1, 5.6). A breast cancer history continued to be a hazard for mortality 6-15 years after diagnosis (HR 1.3, 95 % CI 1.1, 1.4). We found that older breast cancer survivors who developed comorbidities had an increased all-cause mortality rate even after adjusting for age and prevalent comorbidity burden. Additionally, survivors acquire comorbidities at a rate similar to older women free of breast cancer. These results highlight the association between comorbidity burden and long-term mortality risk among older breast cancer survivors and their need for appropriate oncology and primary care follow-up. Five-year breast cancer survivors, diagnosed after 65 years of age, may develop more incident comorbidities than similar populations free of cancer. We investigated whether older breast cancer survivors have a similar comorbidity burden 6-15 years after cancer diagnosis to matched women free of breast cancer at start of follow-up and whether incident comorbidities are associated with all-cause mortality. In this prospective cohort study, 1,361 older 5-year early-stage breast cancer survivors diagnosed between 1990 and 1994 and 1,361 age- and health system-matched women were followed for 10 years. Adjudicated medical record review captured prevalent and incident comorbidities during follow-up or until death as collected from the National Death Index. Older 5-year breast cancer survivors did not acquire incident comorbidities more often than matched women free of breast cancer in the subsequent 10 years [hazard ratio (HR) 1.0, 95 % confidence interval (95 % CI) 0.93, 1.1]. Adjusted for cohort membership, women with incident comorbidities had a higher mortality rate than those without incident comorbidities (HR 4.8, 95 % CI 4.1, 5.6). A breast cancer history continued to be a hazard for mortality 6-15 years after diagnosis (HR 1.3, 95 % CI 1.1, 1.4). We found that older breast cancer survivors who developed comorbidities had an increased all-cause mortality rate even after adjusting for age and prevalent comorbidity burden. Additionally, survivors acquire comorbidities at a rate similar to older women free of breast cancer. These results highlight the association between comorbidity burden and long-term mortality risk among older breast cancer survivors and their need for appropriate oncology and primary care follow-up.[PUBLICATION ABSTRACT] Five-year breast cancer survivors, diagnosed after 65 years of age, may develop more incident comorbidities than similar populations free of cancer. We investigated whether older breast cancer survivors have a similar comorbidity burden 6-15 years after cancer diagnosis to matched women free of breast cancer at start of follow-up and whether incident comorbidities are associated with all-cause mortality. In this prospective cohort study, 1,361 older 5-year early-stage breast cancer survivors diagnosed between 1990 and 1994 and 1,361 age- and health system-matched women were followed for 10 years. Adjudicated medical record review captured prevalent and incident comorbidities during follow-up or until death as collected from the National Death Index. Older 5-year breast cancer survivors did not acquire incident comorbidities more often than matched women free of breast cancer in the subsequent 10 years [hazard ratio (HR) 1.0, 95 % confidence interval (95 % CI) 0.93, 1.1]. Adjusted for cohort membership, women with incident comorbidities had a higher mortality rate than those without incident comorbidities (HR 4.8, 95 % CI 4.1, 5.6). A breast cancer history continued to be a hazard for mortality 6-15 years after diagnosis (HR 1.3, 95 % CI 1.1, 1.4). We found that older breast cancer survivors who developed comorbidities had an increased all-cause mortality rate even after adjusting for age and prevalent comorbidity burden. Additionally, survivors acquire comorbidities at a rate similar to older women free of breast cancer. These results highlight the association between comorbidity burden and long-term mortality risk among older breast cancer survivors and their need for appropriate oncology and primary care follow-up.Five-year breast cancer survivors, diagnosed after 65 years of age, may develop more incident comorbidities than similar populations free of cancer. We investigated whether older breast cancer survivors have a similar comorbidity burden 6-15 years after cancer diagnosis to matched women free of breast cancer at start of follow-up and whether incident comorbidities are associated with all-cause mortality. In this prospective cohort study, 1,361 older 5-year early-stage breast cancer survivors diagnosed between 1990 and 1994 and 1,361 age- and health system-matched women were followed for 10 years. Adjudicated medical record review captured prevalent and incident comorbidities during follow-up or until death as collected from the National Death Index. Older 5-year breast cancer survivors did not acquire incident comorbidities more often than matched women free of breast cancer in the subsequent 10 years [hazard ratio (HR) 1.0, 95 % confidence interval (95 % CI) 0.93, 1.1]. Adjusted for cohort membership, women with incident comorbidities had a higher mortality rate than those without incident comorbidities (HR 4.8, 95 % CI 4.1, 5.6). A breast cancer history continued to be a hazard for mortality 6-15 years after diagnosis (HR 1.3, 95 % CI 1.1, 1.4). We found that older breast cancer survivors who developed comorbidities had an increased all-cause mortality rate even after adjusting for age and prevalent comorbidity burden. Additionally, survivors acquire comorbidities at a rate similar to older women free of breast cancer. These results highlight the association between comorbidity burden and long-term mortality risk among older breast cancer survivors and their need for appropriate oncology and primary care follow-up. Five-year breast cancer survivors, diagnosed after 65 years of age, may develop more incident comorbidities than similar populations free of cancer. We investigated whether older breast cancer survivors have a similar comorbidity burden 6-15 years after cancer diagnosis to matched women free of breast cancer at start of follow-up and whether incident comorbidities are associated with all-cause mortality. In this prospective cohort study, 1,361 older 5-year early-stage breast cancer survivors diagnosed between 1990 and 1994 and 1,361 age- and health system-matched women were followed for 10 years. Adjudicated medical record review captured prevalent and incident comorbidities during follow-up or until death as collected from the National Death Index. Older 5-year breast cancer survivors did not acquire incident comorbidities more often than matched women free of breast cancer in the subsequent 10 years [hazard ratio (HR) 1.0, 95 % confidence interval (95 % CI) 0.93, 1.1]. Adjusted for cohort membership, women with incident comorbidities had a higher mortality rate than those without incident comorbidities (HR 4.8, 95 % CI 4.1, 5.6). A breast cancer history continued to be a hazard for mortality 6-15 years after diagnosis (HR 1.3, 95 % CI 1.1, 1.4). We found that older breast cancer survivors who developed comorbidities had an increased all-cause mortality rate even after adjusting for age and prevalent comorbidity burden. Additionally, survivors acquire comorbidities at a rate similar to older women free of breast cancer. These results highlight the association between comorbidity burden and long-term mortality risk among older breast cancer survivors and their need for appropriate oncology and primary care follow-up. Keywords Breast cancer * Survivorship * Comorbidity * Geriatrics * Managed care * Mortality Five-year breast cancer survivors, diagnosed after 65 years of age, may develop more incident comorbidities than similar populations free of cancer. We investigated whether older breast cancer survivors have a similar comorbidity burden 6–15 years after cancer diagnosis to matched women free of breast cancer at start of follow-up and whether incident comorbidities are associated with all-cause mortality. In this prospective cohort study, 1,361 older 5-year early-stage breast cancer survivors diagnosed between 1990 and 1994 and 1,361 age- and health system-matched women were followed for 10 years. Adjudicated medical record review captured prevalent and incident comorbidities during follow-up or until death as collected from the National Death Index. Older 5-year breast cancer survivors did not acquire incident comorbidities more often than matched women free of breast cancer in the subsequent 10 years [hazard ratio (HR) 1.0, 95 % confidence interval (95 % CI) 0.93, 1.1]. Adjusted for cohort membership, women with incident comorbidities had a higher mortality rate than those without incident comorbidities (HR 4.8, 95 % CI 4.1, 5.6). A breast cancer history continued to be a hazard for mortality 6–15 years after diagnosis (HR 1.3, 95 % CI 1.1, 1.4). We found that older breast cancer survivors who developed comorbidities had an increased all-cause mortality rate even after adjusting for age and prevalent comorbidity burden. Additionally, survivors acquire comorbidities at a rate similar to older women free of breast cancer. These results highlight the association between comorbidity burden and long-term mortality risk among older breast cancer survivors and their need for appropriate oncology and primary care follow-up. |
| Audience | Academic |
| Author | Jordan, Jennifer H. Buist, Diana S. M. Petersen, Hans V. Prout, Marianne N. Quinn, Virginia P. Haque, Reina Yood, Marianne Ulcickas Pawloski, Pamala A. Thwin, Soe Soe Geiger, Ann M. Field, Terry S. Lash, Timothy L. Silliman, Rebecca A. |
| Author_xml | – sequence: 1 givenname: Jennifer H. surname: Jordan fullname: Jordan, Jennifer H. organization: Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest School of Medicine – sequence: 2 givenname: Soe Soe surname: Thwin fullname: Thwin, Soe Soe organization: Section of Geriatrics, Boston Medical Center, Boston University School of Medicine, Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Healthcare System – sequence: 3 givenname: Timothy L. surname: Lash fullname: Lash, Timothy L. organization: Department of Epidemiology, Emory University Rollins School of Public Health – sequence: 4 givenname: Diana S. M. surname: Buist fullname: Buist, Diana S. M. organization: Group Health Research Institute – sequence: 5 givenname: Terry S. surname: Field fullname: Field, Terry S. organization: Meyers Primary Care Institute – sequence: 6 givenname: Reina surname: Haque fullname: Haque, Reina organization: Department of Research and Evaluation, Kaiser Permanente Southern California – sequence: 7 givenname: Pamala A. surname: Pawloski fullname: Pawloski, Pamala A. organization: HealthPartners Institute for Education and Research – sequence: 8 givenname: Hans V. surname: Petersen fullname: Petersen, Hans V. organization: Lovelace Respiratory Research Institute – sequence: 9 givenname: Marianne N. surname: Prout fullname: Prout, Marianne N. organization: Department of Epidemiology, Boston University School of Public Health – sequence: 10 givenname: Virginia P. surname: Quinn fullname: Quinn, Virginia P. organization: Department of Research and Evaluation, Kaiser Permanente Southern California – sequence: 11 givenname: Marianne Ulcickas surname: Yood fullname: Yood, Marianne Ulcickas organization: Department of Epidemiology, Boston University School of Public Health – sequence: 12 givenname: Rebecca A. surname: Silliman fullname: Silliman, Rebecca A. organization: Section of Geriatrics, Boston Medical Center, Boston University School of Medicine – sequence: 13 givenname: Ann M. surname: Geiger fullname: Geiger, Ann M. email: ann.geiger@nih.gov organization: Health Services and Economics Branch (HSEB), Applied Research Program (ARP), Division of Cancer Control and Prevention (DCCPS), National Cancer Institute (NCI) |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24939060$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ktFuFCEUhompsdvqA3hjSExMb6iwM8MM3jWN1k2aeKFeEwbO7NIwsAKzyb5Qn1OmW7Vt1HBBAt9_zg_nP0FHPnhA6DWj54zS9n1itKkFoawmFV0y0j1DC9a0FWmXrD1CC8p4S3hH-TE6SemGUipaKl6g42UtKkE5XaDbldfWgM9YhzHE3hqbLSSsvMHKOaLVlACXm6yczXusxuDXuCF7UBGnKe7sLsSEw4C_ZrUGvLpTrla4j6BSqaq8hoiNVWsfEpSiGc8cb3CIODgD8QNWeBtD2oLOdgdkVFlvCqnDprTFKU9m_xI9H5RL8Op-P0XfP338dvmZXH-5Wl1eXBPNa5EJCK4N6EZUqjf10NBWdIyBqjnrtGkBBFTlUwC46Ouu7ylw3vPKMC0M1U1dnaKzQ91i6McEKcvRJg3OKQ9hSpIVRohm2TQFffsEvQlT9MXdHVXTjtLuD7VWDqT1Q8hR6bmovKi6Mj8uOCvU-V-osgyMVpehD7acPxK8eyDYgHJ5k4Kbsg0-PQbf3Luc-hGM3EY7qriXvxJQAHYAdBlBijD8RhiVc8rkIWWypEzOKZPzo9onGm2zmnsX29b9V7k8KFPp4tcQH3zaP0U_AS8o5Eg |
| CODEN | BCTRD6 |
| CitedBy_id | crossref_primary_10_1007_s00520_022_07023_4 crossref_primary_10_1136_bmjopen_2020_040253 crossref_primary_10_1016_j_ejca_2015_02_001 crossref_primary_10_1007_s10549_018_5025_2 crossref_primary_10_1002_cam4_3272 crossref_primary_10_1007_s10549_018_05078_8 crossref_primary_10_1371_journal_pone_0279656 crossref_primary_10_1097_EDE_0000000000000391 crossref_primary_10_1097_MD_0000000000021498 crossref_primary_10_1097_MD_0000000000018550 crossref_primary_10_1016_j_soncn_2015_02_004 crossref_primary_10_1016_S0140_6736_19_31674_5 crossref_primary_10_1002_cncr_33363 crossref_primary_10_1007_s10549_022_06568_6 crossref_primary_10_1186_s12877_018_0809_0 crossref_primary_10_1007_s10549_016_3773_4 crossref_primary_10_1136_bmjresp_2024_002681 crossref_primary_10_1200_GO_20_00316 crossref_primary_10_3390_cancers14071808 crossref_primary_10_1038_s41523_020_0161_3 crossref_primary_10_1188_15_CJON_E80_E86 crossref_primary_10_5694_mja17_00938 crossref_primary_10_1093_jnci_djaf122 crossref_primary_10_1007_s10552_019_01203_0 crossref_primary_10_1016_j_ejon_2015_01_010 crossref_primary_10_1200_JCO_2016_67_1883 crossref_primary_10_1007_s10549_017_4650_5 crossref_primary_10_1016_j_ejogrb_2024_01_021 crossref_primary_10_1186_s12944_016_0225_4 crossref_primary_10_1245_s10434_024_15000_w crossref_primary_10_1007_s12609_025_00586_1 crossref_primary_10_1016_j_lanwpc_2025_101519 |
| Cites_doi | 10.1093/annonc/mdr486 10.1093/annonc/mdq777 10.1158/1055-9965.EPI-11-0348 10.1200/JCO.2011.35.8408 10.1200/JCO.2009.27.0579 10.1001/jama.1991.03470120074036 10.1080/10428190701471973 10.1200/JCO.2008.21.4023 10.1007/s11606-010-1407-9 10.1186/1756-0500-4-430 10.1016/S1053-4296(03)00024-9 10.1158/1055-9965.EPI-09-0607 10.1093/jncimonographs/lgi032 10.1097/MLR.0b013e318180913c 10.1016/S1047-2797(96)00060-9 10.1200/JCO.2004.00.9753 10.1093/jnci/djr188 10.1007/s00432-004-0594-3 10.1186/1471-2288-7-23 10.1016/0021-9681(87)90171-8 10.1200/JCO.2008.20.3232 10.1093/aje/kwq433 10.1007/s11764-009-0084-3 10.1200/JCO.2006.06.3065 10.1016/S1047-2797(96)00063-4 10.1093/aje/kwm034 10.1016/S0889-8588(05)70275-6 10.1038/bjc.2012.46 10.1038/sj.bjc.6601844 10.1016/j.jclinepi.2012.02.017 |
| ContentType | Journal Article |
| Copyright | Springer Science+Business Media New York 2014 COPYRIGHT 2014 Springer |
| Copyright_xml | – notice: Springer Science+Business Media New York 2014 – notice: COPYRIGHT 2014 Springer |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 K9- K9. M0R M0S M1P M2O MBDVC PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8 |
| DOI | 10.1007/s10549-014-3021-8 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Local Electronic Collection Information ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts Consumer Health Database ProQuest Health & Medical Complete (Alumni) Consumer Health Database ProQuest Health & Medical Collection PML(ProQuest Medical Library) Research Library (subscription) Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Research Library Prep MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: Download PDF from ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1573-7217 |
| EndPage | 409 |
| ExternalDocumentID | 3365288141 A381056961 24939060 10_1007_s10549_014_3021_8 |
| Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01CA093772 – fundername: NCI NIH HHS grantid: R01 CA093772 |
| GroupedDBID | --- -53 -5E -5G -BR -EM -XW -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 23N 28- 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHVE ACHXU ACIHN ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEAQA AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFEXP AFFNX AFJLC AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BKNYI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GRRUI GUQSH GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO ICW IHE IHR IHW IJ- IKXTQ IMOTQ INH INR ITC ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ K9- KDC KOV KOW KPH LAK LLZTM M0R M1P M2O M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UDS UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z7W Z81 Z82 Z83 Z87 Z8O Z8Q Z8U Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZXP ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7TO 7XB 8FK H94 K9. MBDVC PKEHL PQEST PQUKI Q9U 7X8 |
| ID | FETCH-LOGICAL-c649t-e96cdec593abd4f5079811ea4618cd7ee9e3016ee69b48bb0e66b63d1c9d0c543 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 40 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000339330300018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0167-6806 1573-7217 |
| IngestDate | Sun Nov 09 09:18:52 EST 2025 Sat Nov 08 14:36:45 EST 2025 Sat Nov 29 13:25:44 EST 2025 Sat Nov 29 09:50:47 EST 2025 Thu May 22 21:04:51 EDT 2025 Thu Apr 03 07:02:05 EDT 2025 Tue Nov 18 22:53:27 EST 2025 Sat Nov 29 05:41:20 EST 2025 Fri Feb 21 02:33:49 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Breast cancer Survivorship Comorbidity Managed care Mortality Geriatrics |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c649t-e96cdec593abd4f5079811ea4618cd7ee9e3016ee69b48bb0e66b63d1c9d0c543 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://doi.org/10.1007/s10549-014-3021-8 |
| PMID | 24939060 |
| PQID | 1543408008 |
| PQPubID | 36266 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_1543995255 proquest_journals_1543408008 gale_infotracmisc_A381056961 gale_infotracacademiconefile_A381056961 gale_healthsolutions_A381056961 pubmed_primary_24939060 crossref_primary_10_1007_s10549_014_3021_8 crossref_citationtrail_10_1007_s10549_014_3021_8 springer_journals_10_1007_s10549_014_3021_8 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-07-01 |
| PublicationDateYYYYMMDD | 2014-07-01 |
| PublicationDate_xml | – month: 07 year: 2014 text: 2014-07-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Boston |
| PublicationPlace_xml | – name: Boston – name: Netherlands – name: Dordrecht |
| PublicationTitle | Breast cancer research and treatment |
| PublicationTitleAbbrev | Breast Cancer Res Treat |
| PublicationTitleAlternate | Breast Cancer Res Treat |
| PublicationYear | 2014 |
| Publisher | Springer US Springer Springer Nature B.V |
| Publisher_xml | – name: Springer US – name: Springer – name: Springer Nature B.V |
| References | Nekhlyudov (CR33) 2009; 27 Edge, Byrd, Compton, Fritz, Greene, Trotti (CR15) 2010 Yancik, Havlik, Wesley, Ries, Long, Rossi, Edwards (CR7) 1996; 6 Avila, Quinn, Geiger, Kerby, St Charles, Clough-Gorr (CR18) 2011; 4 Charlson, Pompei, Ales, Mackenzie (CR19) 1987; 40 Bosco, Lash, Prout, Buist, Geiger, Haque, Wei, Silliman (CR16) 2009; 18 Quan, Li, Couris, Fushimi, Graham, Hider, Januel, Sundararajan (CR30) 2011; 173 Lash, Fox, Thwin, Geiger, Buist, Wei, Field, Yood, Frost, Quinn, Prout, Silliman (CR20) 2007; 165 Houterman, Janssen-Heijnen, Verheij, Louwman, Vreugdenhil, Van Der Sangen, Coebergh (CR26) 2004; 90 Steinherz, Steinherz, Tan, Heller, Murphy (CR25) 1991; 266 Patnaik, Byers, Diguiseppi, Denberg, Dabelea (CR28) 2011; 103 Braithwaite, Moore, Satariano, Kwan, Hiatt, Kroenke, Caan (CR23) 2012 Haque, Yood, Geiger, Kamineni, Avila, Shi, Silliman, Quinn (CR24) 2011; 20 Hanchate, Clough-Gorr, Ash, Thwin, Silliman (CR11) 2010; 25 Wagner, Greene, Hart, Field, Fletcher, Geiger, Herrinton, Hornbrook, Johnson, Mouchawar, Rolnick, Stevens, Taplin, Tolsma, Vogt (CR14) 2005; 35 Van De Water, Markopoulos, Van De Velde, Seynaeve, Hasenburg, Rea, Putter, Nortier, De Craen, Hille, Bastiaannet, Hadji, Westendorp, Liefers, Jones (CR4) 2012; 307 Jorgensen, Hallas, Friis, Herrstedt (CR9) 2012; 106 Harlan, Klabunde, Ambs, Gibson, Bernstein, Mctiernan, Meeske, Baumgartner, Ballard-Barbash (CR35) 2009; 3 Enger, Thwin, Buist, Field, Frost, Geiger, Lash, Prout, Yood, Wei, Silliman (CR13) 2006; 24 Cheung, Neville, Cameron, Cook, Earle (CR34) 2009; 27 CR29 Nagel, Wedding, Rohrig, Katenkamp (CR27) 2004; 130 Smith, Jiang, Mclaughlin, Hurria, Smith, Giordano, Buchholz (CR3) 2011; 29 CR21 Chavez-Macgregor, Zhao, Kroll, Fang, Zhang, Hortobagyi, Buchholz, Shih, Giordano (CR32) 2011; 22 Guralnik (CR8) 1996; 6 Danese, O’malley, Lindquist, Gleeson, Griffiths (CR22) 2012; 23 Geraci, Escalante, Freeman, Goodwin (CR6) 2005; 23 Yancik, Lag (CR1) 2000; 14 Pal, Hurria (CR5) 2010; 28 Ahern, Lash, Thwin, Silliman (CR12) 2009; 47 (CR2) 2011 Cabanillas, Lu, Fang, Du (CR31) 2007; 48 Thwin, Clough-Gorr, Mccarty, Lash, Alford, Buist, Enger, Field, Frost, Wei, Silliman (CR17) 2007; 7 Aziz, Rowland (CR10) 2003; 13 American Cancer Society (3021_CR2) 2011 TL Lash (3021_CR20) 2007; 165 EH Wagner (3021_CR14) 2005; 35 D Braithwaite (3021_CR23) 2012 R Haque (3021_CR24) 2011; 20 S Houterman (3021_CR26) 2004; 90 R Yancik (3021_CR7) 1996; 6 AD Hanchate (3021_CR11) 2010; 25 ME Charlson (3021_CR19) 1987; 40 LC Harlan (3021_CR35) 2009; 3 JL Patnaik (3021_CR28) 2011; 103 SK Pal (3021_CR5) 2010; 28 SM Enger (3021_CR13) 2006; 24 CC Avila (3021_CR18) 2011; 4 LJ Steinherz (3021_CR25) 1991; 266 ME Cabanillas (3021_CR31) 2007; 48 BD Smith (3021_CR3) 2011; 29 S Edge (3021_CR15) 2010 NM Aziz (3021_CR10) 2003; 13 H Quan (3021_CR30) 2011; 173 R Yancik (3021_CR1) 2000; 14 MD Danese (3021_CR22) 2012; 23 WY Cheung (3021_CR34) 2009; 27 TL Jorgensen (3021_CR9) 2012; 106 W Water Van De (3021_CR4) 2012; 307 M Chavez-Macgregor (3021_CR32) 2011; 22 3021_CR29 G Nagel (3021_CR27) 2004; 130 TP Ahern (3021_CR12) 2009; 47 SS Thwin (3021_CR17) 2007; 7 JLF Bosco (3021_CR16) 2009; 18 3021_CR21 L Nekhlyudov (3021_CR33) 2009; 27 JM Guralnik (3021_CR8) 1996; 6 JM Geraci (3021_CR6) 2005; 23 17577410 - BMC Med Res Methodol. 2007;7:23 22067407 - J Clin Oncol. 2011 Dec 10;29(35):4647-53 22573797 - Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1115-25 12903014 - Semin Radiat Oncol. 2003 Jul;13(3):248-66 22039090 - Ann Oncol. 2012 Jul;23(7):1756-65 21330339 - Am J Epidemiol. 2011 Mar 15;173(6):676-82 19843686 - Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2979-83 8915467 - Ann Epidemiol. 1996 Sep;6(5):376-80 8915471 - Ann Epidemiol. 1996 Sep;6(5):399-412 20532657 - J Gen Intern Med. 2010 Oct;25(10):1045-50 16234509 - J Clin Oncol. 2005 Oct 20;23(30):7399-404 21393379 - Ann Oncol. 2011 Nov;22(11):2394-402 19332710 - J Clin Oncol. 2009 May 20;27(15):2424-6 21719777 - J Natl Cancer Inst. 2011 Jul 20;103(14):1101-11 16287880 - J Natl Cancer Inst Monogr. 2005;(35):3-11 22739245 - J Clin Epidemiol. 2012 Sep;65(9):924-33 21878589 - Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2120-6 17701582 - Leuk Lymphoma. 2007 Aug;48(8):1514-21 20644100 - J Clin Oncol. 2010 Sep 10;28(26):4086-93 10680069 - Hematol Oncol Clin North Am. 2000 Feb;14(1):17-23 1886191 - JAMA. 1991 Sep 25;266(12):1672-7 22353805 - Br J Cancer. 2012 Mar 27;106(7):1353-60 19437121 - J Cancer Surviv. 2009 Jun;3(2):89-98 17406006 - Am J Epidemiol. 2007 Jun 15;165(12):1454-61 16983106 - J Clin Oncol. 2006 Sep 20;24(27):4377-83 19332716 - J Clin Oncol. 2009 May 20;27(15):2489-95 15162155 - Br J Cancer. 2004 Jun 14;90(12):2332-7 3558716 - J Chronic Dis. 1987;40(5):373-83 15300426 - J Cancer Res Clin Oncol. 2004 Nov;130(11):664-70 22013969 - BMC Res Notes. 2011 Oct 20;4:430 22318280 - JAMA. 2012 Feb 8;307(6):590-7 19106734 - Med Care. 2009 Jan;47(1):73-9 |
| References_xml | – volume: 90 start-page: 2332 issue: 12 year: 2004 end-page: 2337 ident: CR26 article-title: Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients publication-title: Br J Cancer – volume: 23 start-page: 1756 issue: 7 year: 2012 end-page: 1765 ident: CR22 article-title: An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer publication-title: Ann Oncol doi: 10.1093/annonc/mdr486 – volume: 22 start-page: 2394 issue: 11 year: 2011 end-page: 2402 ident: CR32 article-title: Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer publication-title: Ann Oncol doi: 10.1093/annonc/mdq777 – volume: 20 start-page: 2120 issue: 10 year: 2011 end-page: 2126 ident: CR24 article-title: Long-term safety of radiotherapy and breast cancer laterality in older survivors publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-11-0348 – year: 2011 ident: CR2 publication-title: Breast cancer facts & figures 2011–2012 – volume: 29 start-page: 4647 issue: 35 year: 2011 end-page: 4653 ident: CR3 article-title: Improvement in breast cancer outcomes over time: are older women missing out? publication-title: J Clin Oncol doi: 10.1200/JCO.2011.35.8408 – volume: 28 start-page: 4086 issue: 26 year: 2010 end-page: 4093 ident: CR5 article-title: Impact of age, sex, and comorbidity on cancer therapy and disease progression publication-title: J Clin Oncol doi: 10.1200/JCO.2009.27.0579 – volume: 266 start-page: 1672 issue: 12 year: 1991 end-page: 1677 ident: CR25 article-title: Cardiac toxicity 4 to 20 years after completing anthracycline therapy publication-title: J Am Med Assoc doi: 10.1001/jama.1991.03470120074036 – volume: 48 start-page: 1514 issue: 8 year: 2007 end-page: 1521 ident: CR31 article-title: Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures publication-title: Leuk Lymphoma doi: 10.1080/10428190701471973 – ident: CR29 – volume: 307 start-page: 590 issue: 6 year: 2012 end-page: 597 ident: CR4 article-title: Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer publication-title: J Am Med Assoc – volume: 27 start-page: 2424 issue: 15 year: 2009 end-page: 2426 ident: CR33 article-title: “Doc, should i see you or my oncologist?” A primary care perspective on opportunities and challenges in providing comprehensive care for cancer survivors publication-title: J Clin Oncol doi: 10.1200/JCO.2008.21.4023 – volume: 25 start-page: 1045 issue: 10 year: 2010 end-page: 1050 ident: CR11 article-title: Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis publication-title: J Gen Intern Med doi: 10.1007/s11606-010-1407-9 – volume: 4 start-page: 430 year: 2011 ident: CR18 article-title: Webinar training: an acceptable, feasible and effective approach for multi-site medical record abstraction: the BOWII experience publication-title: BMC Res Notes doi: 10.1186/1756-0500-4-430 – volume: 13 start-page: 248 issue: 3 year: 2003 end-page: 266 ident: CR10 article-title: Trends and advances in cancer survivorship research: challenge and opportunity publication-title: Semin Radiat Oncol doi: 10.1016/S1053-4296(03)00024-9 – volume: 18 start-page: 2979 issue: 11 year: 2009 end-page: 2983 ident: CR16 article-title: Breast cancer recurrence in older women five to ten years after diagnosis publication-title: Cancer Epidemiol Biomark doi: 10.1158/1055-9965.EPI-09-0607 – volume: 35 start-page: 3 year: 2005 end-page: 11 ident: CR14 article-title: Building a research consortium of large health systems: the cancer research network publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgi032 – volume: 47 start-page: 73 issue: 1 year: 2009 end-page: 79 ident: CR12 article-title: Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors publication-title: Med Care doi: 10.1097/MLR.0b013e318180913c – ident: CR21 – volume: 6 start-page: 376 issue: 5 year: 1996 end-page: 380 ident: CR8 article-title: Assessing the impact of comorbidity in the older population publication-title: Ann Epidemiol doi: 10.1016/S1047-2797(96)00060-9 – year: 2012 ident: CR23 article-title: Prognostic impact of comorbidity among long-term breast cancer survivors: results from the lace study publication-title: Cancer Epidemiol Biomarkers Prev – volume: 23 start-page: 7399 issue: 30 year: 2005 end-page: 7404 ident: CR6 article-title: Comorbid disease and cancer: the need for more relevant conceptual models in health services research publication-title: J Clin Oncol doi: 10.1200/JCO.2004.00.9753 – volume: 103 start-page: 1101 issue: 14 year: 2011 end-page: 1111 ident: CR28 article-title: The influence of comorbidities on overall survival among older women diagnosed with breast cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djr188 – volume: 130 start-page: 664 issue: 11 year: 2004 end-page: 670 ident: CR27 article-title: The impact of comorbidity on the survival of postmenopausal women with breast cancer publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-004-0594-3 – volume: 7 start-page: 23 year: 2007 ident: CR17 article-title: Automated inter-rater reliability assessment and electronic data collection in a multi-center breast cancer study publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-7-23 – volume: 40 start-page: 373 issue: 5 year: 1987 end-page: 383 ident: CR19 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J Chronic Dis doi: 10.1016/0021-9681(87)90171-8 – volume: 27 start-page: 2489 issue: 15 year: 2009 end-page: 2495 ident: CR34 article-title: Comparisons of patient and physician expectations for cancer survivorship care publication-title: J Clin Oncol doi: 10.1200/JCO.2008.20.3232 – volume: 173 start-page: 676 issue: 6 year: 2011 end-page: 682 ident: CR30 article-title: Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries publication-title: Am J Epidemiol doi: 10.1093/aje/kwq433 – volume: 3 start-page: 89 issue: 2 year: 2009 end-page: 98 ident: CR35 article-title: Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer publication-title: J Cancer Surviv doi: 10.1007/s11764-009-0084-3 – volume: 24 start-page: 4377 issue: 27 year: 2006 end-page: 4383 ident: CR13 article-title: Breast cancer treatment of older women in integrated health care settings publication-title: J Clin Oncol doi: 10.1200/JCO.2006.06.3065 – volume: 6 start-page: 399 issue: 5 year: 1996 end-page: 412 ident: CR7 article-title: Cancer and comorbidity in older patients: a descriptive profile publication-title: Ann Epidemiol doi: 10.1016/S1047-2797(96)00063-4 – volume: 165 start-page: 1454 issue: 12 year: 2007 end-page: 1461 ident: CR20 article-title: Using probabilistic corrections to account for abstractor agreement in medical record reviews publication-title: Am J Epidemiol doi: 10.1093/aje/kwm034 – volume: 14 start-page: 17 issue: 1 year: 2000 end-page: 23 ident: CR1 article-title: Cancer and aging in America—demographic and epidemiologic perspectives publication-title: Hematol Oncol Clin N Am doi: 10.1016/S0889-8588(05)70275-6 – year: 2010 ident: CR15 publication-title: AJCC cancer staging manual – volume: 106 start-page: 1353 issue: 7 year: 2012 end-page: 1360 ident: CR9 article-title: Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality publication-title: Br J Cancer doi: 10.1038/bjc.2012.46 – volume: 4 start-page: 430 year: 2011 ident: 3021_CR18 publication-title: BMC Res Notes doi: 10.1186/1756-0500-4-430 – volume: 165 start-page: 1454 issue: 12 year: 2007 ident: 3021_CR20 publication-title: Am J Epidemiol doi: 10.1093/aje/kwm034 – volume: 18 start-page: 2979 issue: 11 year: 2009 ident: 3021_CR16 publication-title: Cancer Epidemiol Biomark doi: 10.1158/1055-9965.EPI-09-0607 – volume: 90 start-page: 2332 issue: 12 year: 2004 ident: 3021_CR26 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601844 – volume: 47 start-page: 73 issue: 1 year: 2009 ident: 3021_CR12 publication-title: Med Care doi: 10.1097/MLR.0b013e318180913c – volume: 20 start-page: 2120 issue: 10 year: 2011 ident: 3021_CR24 publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-11-0348 – volume: 13 start-page: 248 issue: 3 year: 2003 ident: 3021_CR10 publication-title: Semin Radiat Oncol doi: 10.1016/S1053-4296(03)00024-9 – volume: 103 start-page: 1101 issue: 14 year: 2011 ident: 3021_CR28 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djr188 – volume: 7 start-page: 23 year: 2007 ident: 3021_CR17 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-7-23 – volume: 3 start-page: 89 issue: 2 year: 2009 ident: 3021_CR35 publication-title: J Cancer Surviv doi: 10.1007/s11764-009-0084-3 – volume: 307 start-page: 590 issue: 6 year: 2012 ident: 3021_CR4 publication-title: J Am Med Assoc – year: 2012 ident: 3021_CR23 publication-title: Cancer Epidemiol Biomarkers Prev – volume: 25 start-page: 1045 issue: 10 year: 2010 ident: 3021_CR11 publication-title: J Gen Intern Med doi: 10.1007/s11606-010-1407-9 – volume: 23 start-page: 1756 issue: 7 year: 2012 ident: 3021_CR22 publication-title: Ann Oncol doi: 10.1093/annonc/mdr486 – volume: 173 start-page: 676 issue: 6 year: 2011 ident: 3021_CR30 publication-title: Am J Epidemiol doi: 10.1093/aje/kwq433 – volume: 22 start-page: 2394 issue: 11 year: 2011 ident: 3021_CR32 publication-title: Ann Oncol doi: 10.1093/annonc/mdq777 – volume: 106 start-page: 1353 issue: 7 year: 2012 ident: 3021_CR9 publication-title: Br J Cancer doi: 10.1038/bjc.2012.46 – volume: 48 start-page: 1514 issue: 8 year: 2007 ident: 3021_CR31 publication-title: Leuk Lymphoma doi: 10.1080/10428190701471973 – volume: 40 start-page: 373 issue: 5 year: 1987 ident: 3021_CR19 publication-title: J Chronic Dis doi: 10.1016/0021-9681(87)90171-8 – volume: 14 start-page: 17 issue: 1 year: 2000 ident: 3021_CR1 publication-title: Hematol Oncol Clin N Am doi: 10.1016/S0889-8588(05)70275-6 – volume: 29 start-page: 4647 issue: 35 year: 2011 ident: 3021_CR3 publication-title: J Clin Oncol doi: 10.1200/JCO.2011.35.8408 – volume-title: AJCC cancer staging manual year: 2010 ident: 3021_CR15 – volume: 266 start-page: 1672 issue: 12 year: 1991 ident: 3021_CR25 publication-title: J Am Med Assoc doi: 10.1001/jama.1991.03470120074036 – volume: 27 start-page: 2424 issue: 15 year: 2009 ident: 3021_CR33 publication-title: J Clin Oncol doi: 10.1200/JCO.2008.21.4023 – volume: 27 start-page: 2489 issue: 15 year: 2009 ident: 3021_CR34 publication-title: J Clin Oncol doi: 10.1200/JCO.2008.20.3232 – volume: 130 start-page: 664 issue: 11 year: 2004 ident: 3021_CR27 publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-004-0594-3 – ident: 3021_CR29 doi: 10.1016/j.jclinepi.2012.02.017 – volume: 23 start-page: 7399 issue: 30 year: 2005 ident: 3021_CR6 publication-title: J Clin Oncol doi: 10.1200/JCO.2004.00.9753 – volume: 6 start-page: 399 issue: 5 year: 1996 ident: 3021_CR7 publication-title: Ann Epidemiol doi: 10.1016/S1047-2797(96)00063-4 – ident: 3021_CR21 – volume-title: Breast cancer facts & figures 2011–2012 year: 2011 ident: 3021_CR2 – volume: 35 start-page: 3 year: 2005 ident: 3021_CR14 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgi032 – volume: 28 start-page: 4086 issue: 26 year: 2010 ident: 3021_CR5 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.27.0579 – volume: 6 start-page: 376 issue: 5 year: 1996 ident: 3021_CR8 publication-title: Ann Epidemiol doi: 10.1016/S1047-2797(96)00060-9 – volume: 24 start-page: 4377 issue: 27 year: 2006 ident: 3021_CR13 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.06.3065 – reference: 21719777 - J Natl Cancer Inst. 2011 Jul 20;103(14):1101-11 – reference: 22573797 - Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1115-25 – reference: 16983106 - J Clin Oncol. 2006 Sep 20;24(27):4377-83 – reference: 22739245 - J Clin Epidemiol. 2012 Sep;65(9):924-33 – reference: 19332716 - J Clin Oncol. 2009 May 20;27(15):2489-95 – reference: 19332710 - J Clin Oncol. 2009 May 20;27(15):2424-6 – reference: 20644100 - J Clin Oncol. 2010 Sep 10;28(26):4086-93 – reference: 1886191 - JAMA. 1991 Sep 25;266(12):1672-7 – reference: 17577410 - BMC Med Res Methodol. 2007;7:23 – reference: 21393379 - Ann Oncol. 2011 Nov;22(11):2394-402 – reference: 19843686 - Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2979-83 – reference: 17406006 - Am J Epidemiol. 2007 Jun 15;165(12):1454-61 – reference: 22318280 - JAMA. 2012 Feb 8;307(6):590-7 – reference: 22353805 - Br J Cancer. 2012 Mar 27;106(7):1353-60 – reference: 20532657 - J Gen Intern Med. 2010 Oct;25(10):1045-50 – reference: 16287880 - J Natl Cancer Inst Monogr. 2005;(35):3-11 – reference: 17701582 - Leuk Lymphoma. 2007 Aug;48(8):1514-21 – reference: 22039090 - Ann Oncol. 2012 Jul;23(7):1756-65 – reference: 19437121 - J Cancer Surviv. 2009 Jun;3(2):89-98 – reference: 21878589 - Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2120-6 – reference: 15162155 - Br J Cancer. 2004 Jun 14;90(12):2332-7 – reference: 15300426 - J Cancer Res Clin Oncol. 2004 Nov;130(11):664-70 – reference: 12903014 - Semin Radiat Oncol. 2003 Jul;13(3):248-66 – reference: 10680069 - Hematol Oncol Clin North Am. 2000 Feb;14(1):17-23 – reference: 16234509 - J Clin Oncol. 2005 Oct 20;23(30):7399-404 – reference: 8915467 - Ann Epidemiol. 1996 Sep;6(5):376-80 – reference: 8915471 - Ann Epidemiol. 1996 Sep;6(5):399-412 – reference: 22013969 - BMC Res Notes. 2011 Oct 20;4:430 – reference: 21330339 - Am J Epidemiol. 2011 Mar 15;173(6):676-82 – reference: 22067407 - J Clin Oncol. 2011 Dec 10;29(35):4647-53 – reference: 3558716 - J Chronic Dis. 1987;40(5):373-83 – reference: 19106734 - Med Care. 2009 Jan;47(1):73-9 |
| SSID | ssj0009709 |
| Score | 2.2970488 |
| Snippet | Five-year breast cancer survivors, diagnosed after 65 years of age, may develop more incident comorbidities than similar populations free of cancer. We... Five-year breast cancer survivors, diagnosed after 65 years of age, may develop more incident comorbidities than similar populations free of cancer. We... |
| SourceID | proquest gale pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 401 |
| SubjectTerms | Age Factors Aged Aged, 80 and over Analysis Breast cancer Breast Neoplasms - epidemiology Breast Neoplasms - mortality Breast Neoplasms - pathology Cancer Cancer research Cancer therapies Cause of Death Comorbidity Epidemiology Female Follow-Up Studies Health aspects Humans Incidence Medical records Medicine Medicine & Public Health Mortality Neoplasm Staging Older people Oncology Oncology, Experimental Prevalence Prospective Studies Survivor Survivors Women |
| SummonAdditionalLinks | – databaseName: Springer Journals New Starts & Take-Overs Collection dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ti9QwEA56ivjFd73VU0cQBCXQbts08dshHi7oIb5x30qTTI-DtT3a7oF_yN_pTNru7R4q6OdOZtPsk5lJM_OMEM9Rl-QXcC4rb41MNebSpl5Lb522qOy8zEKh8Pv88FAfHZmPYx13N2W7T1eSwVJvFLvRWYaOvvwlfx5LfVlcIW-nuV_Dp8_fzpl28yGvgwm9lY7UdJX5OxVbzuiiSd7wSRcuSYPvObj5X7O-JW6MoSbsD9i4LS5hfUdc-zBept8VP8k2cEvRHkhV09oTH9hVoaw9lMuldOWqQ_ge4nOK1SH0JYJM_qDNAd2KbMxZ03bQVEAR6zHCIoxcLMByojtpZUC14IdkPiSlPbCcyqBpoeH24K-hBFqIqdxTUvhMIPLAbXvbHgL37T3x9eDtlzfv5Ni2QTqVml6iUc6jy0xSWp9WFHAaHcdYpirWzueIBsmqKERlbKqtjVApqxIfO-Mjl6XJfbFTNzXuCpgnltCCeRVhmiZRVaqMXK7TGNuUArFkJqLp_yvcyGnOrTWWxTkbM69_Qetf8PoXeiZeroecDoQefxN-yqAohprUtTEo9pkXLVNGxTPxIkiwOaBfduVY1UDzZ2KtLcm9LUnaxm778QS8YjQjXRFz4S_H9DSTZ-vHPJJT42psVoOMMRkdDWfiwQDY9YvR2ToxkYpm4tWEzg3lf3rrh_8k_UhcnzO8Qwrzntjp2xU-FlfdWX_StU_C3vwF3BIyaQ priority: 102 providerName: Springer Nature |
| Title | Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study |
| URI | https://link.springer.com/article/10.1007/s10549-014-3021-8 https://www.ncbi.nlm.nih.gov/pubmed/24939060 https://www.proquest.com/docview/1543408008 https://www.proquest.com/docview/1543995255 |
| Volume | 146 |
| WOSCitedRecordID | wos000339330300018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Consumer Health Database (subscription) customDbUrl: eissn: 1573-7217 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0009709 issn: 0167-6806 databaseCode: M0R dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: Download PDF from ProQuest Central customDbUrl: eissn: 1573-7217 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0009709 issn: 0167-6806 databaseCode: BENPR dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Download PDF from ProQuest Public Health customDbUrl: eissn: 1573-7217 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0009709 issn: 0167-6806 databaseCode: 8C1 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1573-7217 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0009709 issn: 0167-6806 databaseCode: 7X7 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library (subscription) customDbUrl: eissn: 1573-7217 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0009709 issn: 0167-6806 databaseCode: M2O dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1573-7217 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009709 issn: 0167-6806 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagRYgLb2igFCMhIYGs5unYXFCpWrESXary0N6i2J5FlbabkmQr8Yf4ncw4yW63Er1wsRRl7MTx55lx5sXYa1AlygWIxdQZLVIFuTCpU8IZqwxIE5eZDxT-nI_HajLRx_0Pt6Z3qxx4omfUrrL0j3w3ohhIUm_Uh_NfgqpGkXW1L6Fxk21S2WzCeT7JV0l3887Fg3J7SxXKwarZhc7hyQgP0mQXiCOh1uTSVe58STxdsZd6MXR4738ncJ_d7RVQvtch5gG7AfOH7PZRb2J_xP4gx6BCoy3HYavanDqfc5WXc8fL2UzYctEAP_NaO2rw3Fcr4pn4jVuGNwvkPBdV3fBqylGP_Ql85HuORtyQ-zuOSjCruetc_AAHbTnRyYxXNa-oaPh7XnKc3BAEKlCpRmg5TsV865b7jLiP2ffDg2_7n0RfzEFYmepWgJbWgc10UhqXTlEN1SqKoExlpKzLATQgr5EAUptUGROClEYmLrLahRa_3RO2Ma_msMV4nBjEEOTTENI0CaelzFAQWwWRSVE9SwIWDktZ2D7TORXcmBWrHM20-gWufkGrX6iAvV12Oe_SfFxH_JLwUXSRqksWUexRtrRMahkF7I2nICaBT7ZlH-uA70_pttYot9cocXPb9dsDmIqeuTTFCkkBe7W8TT3JYW4O1aKj0TrDA2PAnnbYXU4MT9yJDmUYsHcDmC8N_q9ZP7v-VZ6zOzHtJu_JvM022noBL9gte9GeNvWO35e-Vdiq_WiHbX48GB-f4NVR6Nv4C7YnX3_8BX2YQy8 |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQcCF9yNQqJFASCCLPL02EkIVUHXV7cKhSL2F2J5FlZZNSbJF_UMc-Y3MOMlutxK99cA5Y8d2vnnF82DsOagC9QLEYuKMFqmCgTCpU8IZqwxIExeZTxQeDcZjdXCgv6yxP30uDIVV9jLRC2pXWvpH_iaiHEgyb9T7o5-CukbR7WrfQqOFxS6c_EKXrX43_Ijf90Ucb3_a_7Ajuq4CwspUNwK0tA5sppPCuHSC9pBWUQRFKiNl3QBAA4JeAkhtUmVMCFIambjIahdaXAXOe4ldTskTolDB-POyyO-gDSmhWuJShbK_RW1T9dATQ8ed7iHiSKgVPXhWG5xSh2fuZ73a2775vx3YLXajM7D5VssRt9kazO6wq3tdCMFd9hslIjVSbThuo6zMofM1ZXkxc7yYToUt5jXwH94rQQ-F-25MPBMnuBVez1GyHpdVzcsJRzv9O_ChHzkcckPh_TgrsVHFXRvCCDhpw4lOZryseElN0d_yguNh9kmuAp0GZB3HqVlx1XBf8fce-3ohp3Sfrc_KGTxkPE4M8ggMJiGkaRJOCpmhoWEVRCZF8zMJWNhDJ7ddJXdqKDLNlzWoCW05oi0ntOUqYK8WQ47aMibnEW8SHvM2E3chAvMtqgaXSS2jgL30FCQE8c226HI5cP1UTmyFcmOFEoWXXX3cgzfvhGedL5EbsGeLxzSSAgJnUM5bGq0zdIgD9qDllcXG4lQnOpRhwF73zHNq8n_t-tH5S9lk13b290b5aDjefcyux8TJPmp7g6031RyesCv2uDmsq6deJnD27aJ56i9Mv5t_ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9QwELZKQRUv3EegUCOBkEBWczo2EkIVpWLVdlUhkPqWxvYEVVo2JckW9Q_xI_h1zOTY7Vaib33gOWPHduaMZ75h7CWoHO0ChKJwRotYQSpM7JRwxioD0oR50hYK76XjsTo81Acr7M9QC0NplYNObBW1Ky39I98MqAaS3Bu1WfRpEQfbOx9OfgrqIEU3rUM7jY5FduHsF4Zv9fvRNn7rV2G48-nrx8-i7zAgrIx1I0BL68AmOsqNiwv0jbQKAshjGSjrUgANKAASQGoTK2N8kNLIyAVWO9_iinDea-x6Gich4fbv-18WgL9pl15CuOJS-XK4Ue3K9jAqwyCe7iTCQKglm3jRMpwzjRfualsTuHP7fz68O-xW73jzrU5S7rIVmN5ja_t9asF99hs1JTVYbThuqazMsWuxZnk-dTyfTITNZzXwH220gpELb7s08USc4VZ4PUONe1pWNS8Ljv77d-CjduRoxA2l_eOsJF4Vd11qI-CkDSc6mfCy4iU1S3_Hc44HOxS_CgwmUKQcpybGVcNbJOAH7NuVnNJDtjotp_CY8TAyKDuQFj7EceQXuUzQAbEKAhOjWxp5zB_YKLM9wjs1GplkC2xq4rwMOS8jzsuUx97Mh5x08CaXEW8Qb2Zdhe5cNWZbhBKXSC0Dj71uKUg54ptt3td44PoJZmyJcn2JEpWaXX48MHLWK9U6W3Cxx17MH9NIShScQjnraLROMFD22KNObuYbC2MdaV_6Hns7CNK5yf-16yeXL2WDraEoZXuj8e5TdjMkoW6TudfZalPN4Bm7YU-b47p63qoHzo6uWqT-AiL3pEU |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Incident+comorbidities+and+all-cause+mortality+among+5-year+survivors+of+Stage+I+and+II+breast+cancer+diagnosed+at+age+65+or+older%3A+a+prospective-matched+cohort+study&rft.jtitle=Breast+cancer+research+and+treatment&rft.au=Jordan%2C+Jennifer+H&rft.au=Thwin%2C+Soe+Soe&rft.au=Lash%2C+Timothy+L&rft.au=Buist%2C+Diana+S%3B+M&rft.date=2014-07-01&rft.pub=Springer+Nature+B.V&rft.issn=0167-6806&rft.eissn=1573-7217&rft.volume=146&rft.issue=2&rft.spage=401&rft_id=info:doi/10.1007%2Fs10549-014-3021-8&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3365288141 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-6806&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-6806&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-6806&client=summon |